A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Clinical trial NCT07059000 · RECRUITING

Trial details

NCT number: NCT07059000
Sponsor: Kedrion S.p.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Primary Immune Thrombocytopenia (ITP)

Start date: 2025-08-13
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.